From paint thinners to fuels: Could workplace chemicals play a role in Parkinson’s disease?

An analysis of more than 41,000 people examines whether chemicals encountered in everyday industrial workplaces could help explain the origins of a neurological disease that often emerges decades later.

Study: Occupational solvent exposure and Parkinson’s disease: evidence from PPMI online. Image Credit: meeboonstudio / Shutterstock

Study: Occupational solvent exposure and Parkinson’s disease: evidence from PPMI online. Image Credit: meeboonstudio / Shutterstock

In a recent study published in the journal Scientific Reports, researchers evaluated the association between occupational solvent exposure and Parkinson’s disease (PD) using data from the Parkinson’s Progression Markers Initiative (PPMI) Online study. Reported exposure to seven individual solvents was associated with higher odds of PD. When all 13 solvents were assessed simultaneously, positive associations persisted for kerosene, trichloroethylene (TCE), mineral spirits, and carbon tetrachloride. Participants reporting exposure to more solvents had progressively higher odds of PD. The findings identify occupational solvent exposure as a potentially modifiable risk factor for PD, but do not establish causality.

Scientists from the School of Medicine and Health Sciences at Tecnológico de Monterrey and the Institute of Neurology and Neurosurgery at TecSalud’s Zambrano Hellion Medical Center in Mexico conducted the research. 

PD is an increasingly common neurodegenerative condition associated with considerable health and economic burdens across the globe. Population aging partly explains the increasing prevalence of PD, while studies have linked the disease to environmental and occupational exposures, including air pollution, pesticide use, industrial chemicals, and heavy metals. Because solvents are seldom encountered alone and exposure to such chemicals is common, a better understanding of how specific organic solvents contribute to PD risk could inform public health policies aimed at limiting solvent exposure.

About the study

In the present cross-sectional study, the researchers investigated whether occupational exposure to multiple solvents was associated with higher odds of PD among 41,315 participants in the PPMI Online study, using data from a module on workplace chemical exposures. Recruitment was restricted to the United States (US). The team examined self-reported workplace use of 13 solvent categories for at least 100 days over a lifetime among participants who reported a physician diagnosis of PD (10,297 cases) and those who did not report such a diagnosis (31,018 controls).

Logistic regression models were used to estimate the adjusted odds of PD after accounting for the influence of sex, educational attainment, household income, smoking status, caffeine intake, and traumatic brain injuries involving loss of consciousness. Age was not recorded for controls and could not be included in the statistical models, a major limitation since age is the strongest risk factor for PD.

The researchers also collected information on depressive symptoms, motor and non-motor experiences of daily living, and genetic testing results. Potential inaccuracies in self-reported genetic data and small numbers of exposed genetic variant carriers prevented formal analyses of gene-environment interactions. The fully adjusted analyses included 33,709 individuals. The team corrected for multiple statistical comparisons in the individual solvent analyses to reduce the likelihood of chance findings.

The cumulative analysis considered how many different solvents participants had used and the age periods during which they used them, using 10-year intervals before age 50. In the sensitivity analyses, the researchers examined residential location, occupational exposure to pesticides and welding, and cumulative lifetime cigarette consumption (pack-years) instead of smoking status. To estimate the time between exposure and diagnosis, they subtracted the estimated age at first reported exposure from the age at PD diagnosis, using the midpoint of the earliest reported exposure age band to approximate the age at first exposure.

Results and discussion

Most participants were White (approximately 90%), and 56% of PD cases were male. The mean age at diagnosis was 63.5 years, with a median estimated 37.5-year interval between initial exposure and diagnosis among 2,153 participants with PD who reported solvent exposure and had the necessary age data. More than 99% of these participants reported exposure before their PD diagnosis, but both ages were derived from retrospective information.

The team found individual associations between PD and seven solvents, namely kerosene, TCE, mineral spirits, carbon tetrachloride, toluene, jet fuel, and methyl ethyl ketone. When all 13 solvents were assessed simultaneously, positive associations persisted only for kerosene, TCE, carbon tetrachloride, and mineral spirits, which were associated with 50%, 65%, 28%, and 27% higher odds of PD, respectively. Reported use of the remaining three solvents may reflect exposure to broader chemical mixtures rather than independent associations, but statistical adjustment could also obscure their combined effects.

Adjusting for occupational pesticide and welding exposures reduced the estimated associations for individual solvents by up to 20%. Each additional distinct solvent reported was associated with approximately 16% higher odds of PD. Participants reporting exposure to three or more solvents had 52% higher odds than those reporting no exposure.

Solvent exposure before age 50 was also associated with PD, but reporting exposure across more decades did not correspond to progressively higher odds. The number of solvents reported did not reflect actual chemical dose or exposure intensity, and the results could not establish whether these chemicals had additive or interactive biological effects. The findings were largely similar for men and women and across current residential settings, and remained consistent when the researchers accounted for cumulative cigarette consumption instead of smoking status.

TCE demonstrated the strongest and most consistent association, even after adjustment for other occupational exposures. Chlorinated solvents are fat-soluble, which may facilitate central nervous system (CNS) penetration, while compounds such as carbon tetrachloride can promote oxidative stress and mitochondrial dysfunction.

Preclinical research has also linked TCE exposure to disruption of mitochondrial complex I activity and loss of dopaminergic neurons, providing a possible biological explanation that the present study did not directly investigate.

Study limitations

Approximately 26% of participants with PD were unsure which solvents they had used, compared with 15% of controls. Differences in recall and reporting could have inflated or underestimated the observed associations.

The cross-sectional design, self-reported diagnoses, absence of age data for controls, and lack of objective exposure measurements limit causal interpretation. The study did not capture non-occupational solvent exposure through contaminated drinking water or indoor air.

Controls included spouses and family members who may share environmental exposures or genetic characteristics with participants with PD. Smoking status was unknown or unreported for approximately 60% of participants, but separate analyses restricted to individuals with known smoking status supported the main results.

The predominantly White, highly educated study population may also limit the applicability of the findings to the wider workforce.

Conclusion and Future Directions

The associations identified for kerosene, trichloroethylene, mineral spirits, and carbon tetrachloride warrant further investigation as potential occupational contributors to PD. These results may be particularly relevant to painters, mechanics, electricians, and dry-cleaning workers exposed to industrial solvents, but the study did not assess occupation-specific risks.

Exposure to petroleum-derived products, including kerosene and mineral spirits used as fuels, lubricants, degreasers, and paint thinners, warrants further investigation, particularly since previous research on mineral spirits has produced conflicting findings. Evidence of the long-term neurodegenerative effects of kerosene also remains limited.

In future studies, researchers should incorporate objective occupational exposure measurements and clinically confirmed PD cases, alongside genetic data, to improve the validity of the findings. Linking industrial employment records, military service records, and occupational registries with newly diagnosed PD cases could provide documented exposure information that does not rely on participant recall. These records could also be combined with biomonitoring to measure chemical exposure in biological samples and reduce errors in exposure classification.

Source:

Journal reference:
  • Martinez, H.R., Luna-Rangel, F.A., Gutierrez-Treviño, O. et al. (2026). Occupational solvent exposure and Parkinson’s disease: evidence from PPMI online. Scientific Reports, DOI: 10.1038/s41598-026-80567-1, https://www.nature.com/articles/s41598-026-80567-1
Pooja Toshniwal Paharia

Written by

Pooja Toshniwal Paharia

Pooja Toshniwal Paharia is an oral and maxillofacial physician and radiologist based in Pune, India. Her academic background is in Oral Medicine and Radiology. She has extensive experience in research and evidence-based clinical-radiological diagnosis and management of oral lesions and conditions and associated maxillofacial disorders.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Toshniwal Paharia, Pooja Toshniwal Paharia. (2026, November 18). From paint thinners to fuels: Could workplace chemicals play a role in Parkinson’s disease?. News-Medical. Retrieved on November 18, 2026 from https://www.news-medical.net/news/20261118/From-paint-thinners-to-fuels-Could-workplace-chemicals-play-a-role-in-Parkinsone28099s-disease.aspx.

  • MLA

    Toshniwal Paharia, Pooja Toshniwal Paharia. "From paint thinners to fuels: Could workplace chemicals play a role in Parkinson’s disease?". News-Medical. 18 November 2026. <https://www.news-medical.net/news/20261118/From-paint-thinners-to-fuels-Could-workplace-chemicals-play-a-role-in-Parkinsone28099s-disease.aspx>.

  • Chicago

    Toshniwal Paharia, Pooja Toshniwal Paharia. "From paint thinners to fuels: Could workplace chemicals play a role in Parkinson’s disease?". News-Medical. https://www.news-medical.net/news/20261118/From-paint-thinners-to-fuels-Could-workplace-chemicals-play-a-role-in-Parkinsone28099s-disease.aspx. (accessed November 18, 2026).

  • Harvard

    Toshniwal Paharia, Pooja Toshniwal Paharia. 2026. From paint thinners to fuels: Could workplace chemicals play a role in Parkinson’s disease?. News-Medical, viewed 18 November 2026, https://www.news-medical.net/news/20261118/From-paint-thinners-to-fuels-Could-workplace-chemicals-play-a-role-in-Parkinsone28099s-disease.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common chemical exposures in pregnancy may be linked to early attention and memory